IDEXX Laboratories, Inc. (IDXX)
Pre-market:
| Previous close | 497.79 |
| Open | 506.57 |
| Bid | 490.77 x 100 |
| Ask | 492.41 x 100 |
| Day's range | 489.81 - 506.57 |
| 52-week range | 372.50 - 583.39 |
| Volume | |
| Avg. volume | 416,379 |
| Market cap | 40.804B |
| Beta (5Y monthly) | 1.26 |
| PE ratio (TTM) | 48.79 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Business Wire
IDEXX Laboratories to Release 2024 First Quarter Financial Results
WESTBROOK, Maine, April 04, 2024--IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, has scheduled the release of its 2024 first quarter results for Wednesday, May 1, 2024, before the market opens. The Company will conduct an analyst conference call beginning at 8:30 a.m. ET on that day.
- Business Wire
IDEXX Laboratories to Present at Two Upcoming Institutional Investor Conferences
WESTBROOK, Maine, February 20, 2024--IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, will participate in two upcoming conferences:
- PR Newswire
IDEXX Launches Vello™, an Innovative Pet Owner Engagement Software Solution, Streamlining How Practices and Clients Connect
IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, announces the launch of Vello, a software solution that seamlessly connects veterinary practices and clients through modern, digital tools. As the only pet owner engagement solution purpose-built for IDEXX practice management software, Vello enables veterinary practices using ezyVet®, Neo®, and Cornerstone® software to communicate efficiently with pet owners in a single, easy-to-use system. With software-suppo
